| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing Direct > Direct Mail Personalization |
|
Digg It - Direct Mail Personalization
A colleague who does work for a nonprofit organization contacted me asking if I coul According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product d do research on the success rate of personalized direct mail letters (Dear Joe) ver ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in us generically addressed letters (Dear Friend). Surprisingly, I didn't find as many lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tatistics as expected, but I found information stating that personalized letters out here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe perform generic letters. The Digital Printing Council conducted a survey and the re d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ults showed "tailored direct mail pieces increase response rates by more than 500 pe ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc cent over a basic, non-personalized piece." Gotmarketing reports that "perso easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nalizing an email marketing campaign can improve response rates by 45 percent." This nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically one defines customized content and the customer's purchase history as personalizatio and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ . ClickZ shares data from a study that "found personalization was the most i ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi portant factor when contributors determine which charity or fundraising direct mail ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a they open at 62 percent." Second place? Timing at 59 percent. It may cost more to p dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rsonalize the campaign, but the response rate more than makes up the difference than cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin taking the cheap, generic route. When I see mail addressed to "Resident," I promptly tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen throw it in the trash or recycling pile. More resouces: "Personalized donor letter t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel always outperform generic 'Dear Friend' appeals. Donors deserve 'special' treatment ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust and appeals should reinforce the positive relationship you've already established." y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products From FundClass. Mal Warwick & Associates, Inc. learned "personal attention m . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de kes a big difference. The old cliche is true: people give money to people, not organ elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip zations. The more personal the contact, the more effective your fundraising will be. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Advertising; Delivering the Message Part of Marketing Fundraising - Potential New Business on Your Doorstep
|